Table 4. Univariable and Multivariable Cox Proportional Hazards Regression Models for Overall Survival.
Characteristics | Univariable analysis | Multivariable analysis | ||
---|---|---|---|---|
HR (95% CI) | P value | HR (95% CI) | P value | |
MSI testing | ||||
No | 1 [Reference] | NA | 1 [Reference] | NA |
Yes | 0.62 (0.60-0.63) | <.001 | 0.93 (0.91-0.96) | <.001 |
KRAS testing | ||||
No | 1 [Reference] | NA | 1 [Reference] | NA |
Yes | 0.71 (0.69-0.72) | <.001 | 0.97 (0.95-1.00) | .03 |
Age, y | ||||
18-49 | 1 [Reference] | NA | 1 [Reference] | NA |
50-59 | 1.16 (1.12-1.20) | <.001 | 1.06 (1.02-1.10) | .007 |
60-69 | 1.43 (1.38-1.49) | <.001 | 1.16 (1.12-1.21) | <.001 |
70-79 | 1.90 (1.83-1.97) | <.001 | 1.30 (1.24-1.35) | <.001 |
Sex | ||||
Male | 1 [Reference] | NA | 1 [Reference] | NA |
Female | 0.96 (0.94-0.98) | <.001 | 0.98 (0.96-1.00) | .07 |
Ethnicitya | ||||
Non-Hispanic | 1 [Reference] | NA | 1 [Reference] | NA |
Hispanic | 0.83 (0.79-0.87) | <.001 | 0.84 (0.79-0.88) | <.001 |
CCI | ||||
0 | 1 [Reference] | NA | 1 [Reference] | NA |
1 | 1.18 (1.15-1.21) | <.001 | 1.08 (1.05-1.11) | <.001 |
≥2 | 1.60 (1.54-1.66) | <.001 | 1.28 (1.24-1.34) | <.001 |
Grade | ||||
Well-differentiated | 1 [Reference] | NA | 1 [Reference] | NA |
Moderately differentiated | 1.03 (0.97-1.08) | .40 | 1.12 (1.06-1.18) | <.001 |
Poorly differentiated | 1.59 (1.50-1.69) | <.001 | 1.80 (1.70-1.91) | <.001 |
Insurance type | ||||
Private | 1 [Reference] | NA | 1 [Reference] | NA |
No insurance | 1.38 (1.31-1.45) | <.001 | 1.20 (1.14-1.26) | <.001 |
Medicaid | 1.26 (1.21-1.31) | <.001 | 1.14 (1.09-1.18) | <.001 |
Medicare or otherb | 1.56 (1.52-1.60) | <.001 | 1.13 (1.10-1.16) | <.001 |
Unknown | 1.32 (1.19-1.47) | <.001 | 1.08 (0.98-1.20) | .14 |
Educational level in area of residence, %c | ||||
≥17.6 | 1 [Reference] | NA | 1 [Reference] | NA |
10.9-17.5 | 1.03 (1.00-1.06) | .11 | 0.99 (0.96-1.03) | .62 |
6.3-10.8 | 0.97 (0.94-1.00) | .02 | 0.98 (0.94-1.02) | .29 |
Unknown | 1.02 (0.91-1.15) | .69 | 1.06 (0.69-1.62) | .78 |
Facility type with CP | ||||
Academic | 1 [Reference] | NA | 1 [Reference] | NA |
Community | 1.24 (1.19-1.29) | <.001 | 1.07 (1.02-1.12) | .003 |
Comprehensive | 1.20 (1.17-1.23) | <.001 | 1.13 (1.10-1.17) | <.001 |
Integrated network | 1.16 (1.13-1.20) | <.001 | 1.13 (1.09-1.16) | <.001 |
Median household income, US$ | ||||
≥63 333 | 1 [Reference] | NA | 1 [Reference] | NA |
50 354-63 332 | 1.09 (1.06-1.12) | <.001 | 1.05 (1.01-1.08) | .007 |
40 227-50 353 | 1.16 (1.12-1.19) | <.001 | 1.08 (1.04-1.12) | <.001 |
<40 277 | 1.20 (1.17-1.24) | <.001 | 1.10 (1.05-1.15) | <.001 |
Unknown | 1.13 (1.01-1.26) | .04 | 0.97 (0.65-1.46) | .89 |
Year of diagnosis | ||||
2010 | 1 [Reference] | NA | 1 [Reference] | NA |
2011 | 0.96 (0.92-1.00) | .07 | 0.97 (0.93-1.01) | .18 |
2012 | 0.93 (0.89-0.97) | <.001 | 0.92 (0.88-0.96) | <.001 |
2013 | 0.95 (0.91-0.99) | .01 | 0.96 (0.92-1.00) | .07 |
2014 | 0.96 (0.92-1.00) | .05 | 0.98 (0.94-1.02) | .31 |
2015 | 0.91 (0.87-0.95) | <.001 | 0.93 (0.89-0.97) | .002 |
2016 | 0.86 (0.82-0.90) | <.001 | 0.91 (0.87-0.95) | <.001 |
2017 | 0.81 (0.77-0.85) | <.001 | 0.83 (0.79-0.87) | <.001 |
Immunotherapy | ||||
Not administered | 1 [Reference] | NA | 1 [Reference] | NA |
Administered | 0.65 (0.63-0.67) | <.001 | 0.85 (0.82-0.87) | <.001 |
Unknown | 0.85 (0.68-1.05) | .13 | 0.97 (0.77-1.21) | .76 |
Chemotherapy | ||||
Not administered | 1 [Reference] | NA | 1 [Reference] | NA |
Administered | 0.31 (0.30-0.32) | <.001 | 0.37 (0.36-0.38) | <.001 |
Unknown | 0.41 (0.38-0.44) | <.001 | 0.49 (0.45-0.52) | <.001 |
Lung metastasis at presentation | ||||
Absent | 1 [Reference] | NA | 1 [ Reference] | NA |
Present | 1.33 (1.30-1.37) | <.001 | 1.16 (1.13-1.19) | <.001 |
Unknown | 1.51 (1.39-1.64) | <.001 | 1.07 (0.98-1.17) | .14 |
Liver metastasis at presentation | ||||
Absent | 1 [Reference] | NA | 1 [Reference] | NA |
Present | 1.10 (1.07-1.13) | <.001 | 1.27 (1.23-1.30) | <.001 |
Unknown | 1.52 (1.33-1.73) | <.001 | 1.09 (0.95-1.26) | .21 |
Surgery primary site | ||||
No | 1 [Reference] | NA | 1 [Reference] | NA |
Yes | 0.46 (0.45-0.47) | <.001 | 0.53 (0.52-0.55) | <.001 |
Unknown | 0.54 (0.39-0.74) | <.001 | 0.58 (0.42-0.82) | .002 |
Surgery nonprimary site | ||||
No | 1 [Reference] | NA | 1 [Reference] | NA |
Yes | 0.56 (0.54-0.58) | <.001 | 0.81 (0.79-0.84) | <.001 |
Unknown | 0.56 (0.38-0.83) | .003 | 0.78 (0.53-1.15) | .21 |
Area of residence | ||||
Metropolitan | 1 [Reference] | NA | 1 [Reference] | NA |
Urban | 1.11 (1.08-1.15) | <.001 | 1.04 (1.00-1.08) | .07 |
Rural | 1.16 (1.06-1.26) | .001 | 1.11 (1.02-1.22) | .02 |
Facility locationd | ||||
New England | 1 [Reference] | NA | 1 [Reference] | NA |
Middle Atlantic | 0.91 (0.86-0.96) | .001 | 0.85 (0.80-0.90) | <.001 |
South Atlantic | 1.03 (0.98-1.09) | .28 | 1.02 (0.96-1.08) | .56 |
East North Central | 1.08 (1.02-1.14) | .01 | 1.08 (1.02-1.14) | .008 |
East South Central | 1.07 (1.00-1.15) | .04 | 1.03 (0.97-1.11) | .35 |
West North Central | 1.03 (0.97-1.10) | .35 | 1.06 (1.00-1.13) | .07 |
West South Central | 0.96 (0.90-1.02) | .21 | 0.84 (0.79-0.89) | <.001 |
Mountain | 1.01 (0.94-1.09) | .73 | 0.94 (0.87-1.00) | .07 |
Pacific | 0.98 (0.93-1.04) | .50 | 0.98 (0.92-1.04) | .45 |
Travel distance, miles | ||||
≤5 | 1 [Reference] | NA | 1 [Reference] | NA |
5.1-10 | 0.94 (0.92-0.97) | <.001 | 0.98 (0.95-1.01) | .22 |
10.1-25 | 0.90 (0.87-0.93) | <.001 | 0.99 (0.97-1.03) | .75 |
>25 | 0.90 (0.87-0.93) | <.001 | 0.99 (0.96-1.03) | .71 |
Abbreviations: CCI, Charlson Comorbidity Index (range: 0-25, with the highest score indicating a higher number of comorbidities); CP, cancer program; HR, hazard ratio; MSI, microsatellite instability; NA, not applicable.
Ethnicity data obtained from the NCDB were self-identified in the patients’ medical records. Hispanic ethnicity includes Mexican, Puerto Rican, Cuban, South or Central American (except Brazil), Dominican Republic, or Spanish origin.
Other insurance type includes other governmental insurance.
Educational level was assessed at the zip code level based on the percentage of adult residents without a high school diploma.
US Census division.